Logo image of SINT

SINTX TECHNOLOGIES INC (SINT) Stock Fundamental Analysis

NASDAQ:SINT - Nasdaq - US8293927039 - Common Stock - Currency: USD

3.33  -0.14 (-4.03%)

After market: 3.24 -0.09 (-2.7%)

Fundamental Rating

3

SINT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. SINT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SINT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SINT had negative earnings in the past year.
In the past year SINT has reported a negative cash flow from operations.
SINT had negative earnings in each of the past 5 years.
SINT had a negative operating cash flow in each of the past 5 years.
SINT Yearly Net Income VS EBIT VS OCF VS FCFSINT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M

1.2 Ratios

The Return On Assets of SINT (-108.57%) is worse than 82.89% of its industry peers.
SINT has a worse Return On Equity (-204.04%) than 75.40% of its industry peers.
Industry RankSector Rank
ROA -108.57%
ROE -204.04%
ROIC N/A
ROA(3y)-91.86%
ROA(5y)-74.54%
ROE(3y)-222.21%
ROE(5y)-157.01%
ROIC(3y)N/A
ROIC(5y)N/A
SINT Yearly ROA, ROE, ROICSINT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200 -250

1.3 Margins

SINT has a better Gross Margin (67.54%) than 74.87% of its industry peers.
In the last couple of years the Gross Margin of SINT has grown nicely.
The Profit Margin and Operating Margin are not available for SINT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 67.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y40.53%
GM growth 5Y29.13%
SINT Yearly Profit, Operating, Gross MarginsSINT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K

More info and screens

6

2. Health

2.1 Basic Checks

SINT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SINT has more shares outstanding
Compared to 5 years ago, SINT has more shares outstanding
SINT has a worse debt/assets ratio than last year.
SINT Yearly Shares OutstandingSINT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M
SINT Yearly Total Debt VS Total AssetsSINT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of -35.34, we must say that SINT is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of SINT (-35.34) is worse than 94.12% of its industry peers.
There is no outstanding debt for SINT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -35.34
ROIC/WACCN/A
WACC9.3%
SINT Yearly LT Debt VS Equity VS FCFSINT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 3.45 indicates that SINT has no problem at all paying its short term obligations.
SINT's Current ratio of 3.45 is fine compared to the rest of the industry. SINT outperforms 61.50% of its industry peers.
SINT has a Quick Ratio of 3.25. This indicates that SINT is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of SINT (3.25) is better than 65.78% of its industry peers.
Industry RankSector Rank
Current Ratio 3.45
Quick Ratio 3.25
SINT Yearly Current Assets VS Current LiabilitesSINT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 98.22% over the past year.
The Revenue has decreased by -7.42% in the past year.
Measured over the past years, SINT shows a very strong growth in Revenue. The Revenue has been growing by 33.18% on average per year.
EPS 1Y (TTM)98.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.1%
Revenue 1Y (TTM)-7.42%
Revenue growth 3Y68.26%
Revenue growth 5Y33.18%
Sales Q2Q%-46.29%

3.2 Future

Based on estimates for the next years, SINT will show a very strong growth in Earnings Per Share. The EPS will grow by 36.87% on average per year.
SINT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.15% yearly.
EPS Next Y83.05%
EPS Next 2Y36.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-4.02%
Revenue Next 2Y8.15%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SINT Yearly Revenue VS EstimatesSINT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M 20M
SINT Yearly EPS VS EstimatesSINT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 -50M -100M -150M -200M -250M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SINT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SINT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SINT Price Earnings VS Forward Price EarningsSINT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SINT Per share dataSINT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4 -6

4.3 Compensation for Growth

SINT's earnings are expected to grow with 36.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.87%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SINT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SINTX TECHNOLOGIES INC

NASDAQ:SINT (7/11/2025, 8:00:02 PM)

After market: 3.24 -0.09 (-2.7%)

3.33

-0.14 (-4.03%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-15 2025-05-15/bmo
Earnings (Next)08-04 2025-08-04
Inst Owners4.23%
Inst Owner Change0%
Ins Owners0.56%
Ins Owner Change22.1%
Market Cap8.36M
Analysts82.86
Price Target30.6 (818.92%)
Short Float %6.14%
Short Ratio0.78
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-14.46%
Min EPS beat(2)-67.51%
Max EPS beat(2)38.59%
EPS beat(4)3
Avg EPS beat(4)36.68%
Min EPS beat(4)-67.51%
Max EPS beat(4)99.64%
EPS beat(8)5
Avg EPS beat(8)26.56%
EPS beat(12)7
Avg EPS beat(12)-25.17%
EPS beat(16)10
Avg EPS beat(16)-15.03%
Revenue beat(2)0
Avg Revenue beat(2)-37.1%
Min Revenue beat(2)-50.1%
Max Revenue beat(2)-24.09%
Revenue beat(4)2
Avg Revenue beat(4)-10.45%
Min Revenue beat(4)-50.1%
Max Revenue beat(4)20.48%
Revenue beat(8)4
Avg Revenue beat(8)-6.26%
Revenue beat(12)7
Avg Revenue beat(12)9.79%
Revenue beat(16)8
Avg Revenue beat(16)-0.56%
PT rev (1m)0%
PT rev (3m)-57.14%
EPS NQ rev (1m)-19.7%
EPS NQ rev (3m)-33.9%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.04%
Revenue NQ rev (1m)-45.73%
Revenue NQ rev (3m)-30.31%
Revenue NY rev (1m)0%
Revenue NY rev (3m)30.12%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.25
P/FCF N/A
P/OCF N/A
P/B 1.37
P/tB 1.38
EV/EBITDA N/A
EPS(TTM)-7.57
EYN/A
EPS(NY)-2.06
Fwd EYN/A
FCF(TTM)-3.1
FCFYN/A
OCF(TTM)-2.87
OCFYN/A
SpS1.02
BVpS2.43
TBVpS2.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -108.57%
ROE -204.04%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 67.54%
FCFM N/A
ROA(3y)-91.86%
ROA(5y)-74.54%
ROE(3y)-222.21%
ROE(5y)-157.01%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y40.53%
GM growth 5Y29.13%
F-Score4
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 83.82%
Cap/Sales 22.38%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.45
Quick Ratio 3.25
Altman-Z -35.34
F-Score4
WACC9.3%
ROIC/WACCN/A
Cap/Depr(3y)184.27%
Cap/Depr(5y)590.89%
Cap/Sales(3y)44.69%
Cap/Sales(5y)162.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.1%
EPS Next Y83.05%
EPS Next 2Y36.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.42%
Revenue growth 3Y68.26%
Revenue growth 5Y33.18%
Sales Q2Q%-46.29%
Revenue Next Year-4.02%
Revenue Next 2Y8.15%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y36.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year58.24%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y41.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y39.69%
OCF growth 3YN/A
OCF growth 5YN/A